Editas Medicine Names Bernadette Connaughton to Board of
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it...
United Kingdom Bernadette Connaughton Cristi Barnett Bristol Myers Squibb Ron Moldaver Jamesc Mullen
Source: globenewswire.com